YuichiroMori

Partner

(T) 81.3.6800.1827

As a well experienced international lawyer, Yuichiro Mori acts as bridge between Japanese corporations and foreign corporations and facilitates various global transactions. Yuichiro has counseled clients in international and domestic commercial transactions and in international and domestic dispute resolutions for more than 25 years. His experience covers a wide range of matters, including restructurings, M&A, buyouts, and joint ventures, in a variety of industries and jurisdictions. He is frequently appointed by the Tokyo District Court as a bankruptcy trustee. Yuichiro also has served as the Tokyo Office administrative partner since 2015.

Yuichiro represents debtors, creditors, distressed investors, and other stakeholders in insolvency proceedings in a variety of industries. His experience includes the corporate reorganization of Asyst Technologies Japan, as Japanese counsel to the Taiwanese customer; the bankruptcy of Kosugi Sangyo K.K., as Japanese counsel to the licensor for Golden Bear; the civil rehabilitation proceedings of Lehman Brothers Japan, as Japanese counsel to the ultimate parent company of Lehman Brothers Group as creditor; and the chapter 11 proceedings of Lyondell Chemical, as advisor to Sumitomo Chemical, a joint venture partner in Japan. He also successfully led the workout of a Japanese consumer finance company in a ¥43 billion debt restructuring involving 15 commercial banks.

Yuichiro is a member of the Japanese Bar Association, the Dai-ichi Bar Association, and the Nationwide Lawyers Network for Insolvency Proceedings.

Experience

  • Marken acquires PCX International Co., Ltd.Jones Day advised United Parcel Service in the acquisition by its Marken division of PCX International Co., Ltd., a logistics and courier service company specializing in transport of clinical samples in Japan.
  • OMRON Nohgata sells 80 percent stake to AdvantechJones Day advised OMRON Corporation in the sale of an 80 percent interest in OMRON Nohgata to Advantech.
  • Mitsui Chemicals establishes new polypropylene compounds company in NetherlandsJones Day advised Mitsui Chemicals, Inc. in the establishment of Mitsui Prime Advanced Composites Europe B.V. in the Netherlands.
  • PAG invests in Key Safety Systems to finance acquisition of global assets of Takata CorporationJones Day represented PAG Asia Capital Ltd. and PAG Asia II LP in connection with its investment in Key Safety Systems, a subsidiary of China-based Ningbo Joyson Electronic Corporation, to finance the acquisition of substantially all of the global assets of Takata Corporation out of bankruptcy in the U.S. and Japan and certain non-bankruptcy transactions elsewhere in the world.
  • Orocobre Limited secures AUD$361 million funding through private placement and underwritten accelerated entitlement offerJones Day represented Orocobre Limited, a leading lithium chemicals producer, in connection with its AUD$361 million capital raising, comprising of a AUD$282 million private placement to Toyota Tsusho Corporation and an underwritten entitlement offer raising AUD$79 million.
  • Norinchukin and MUFG to strengthen and expand retail business allianceJones Day is advising The Norinchukin Bank, the national-level financial institution for agricultural, fishery, and forestry cooperatives in Japan, in reaching an agreement with Mitsubishi UFJ Financial Group (“MUFG”) on an initiative to enhance the business and capital alliance transaction including the consumer finance business.
  • Cardinal Health acquires leading patient product portfolio from Medtronic for $6.1 billionJones Day advised Cardinal Health on the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash.
  • Total sells Atotech to The Carlyle Group for $3.2 billionJones Day advised Total in the $3.2 billion sale of specialty chemical affiliate Atotech B.V., a global manufacturer of high technology plating solutions, to The Carlyle Group.
  • Takeda Pharmaceutical undergoes investigation involving alleged misconduct relating to investigator-initiated sponsored study on hypertension medicineJones Day, as a third-party organization, conducted an investigation for Takeda Pharmaceutical Company Limited in a matter involving alleged misconduct relating to an investigator-initiated sponsored study on its hypertension medicine, known as Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J).
  • Asia-wide distributor of cosmetics disputes wrongful termination of distributorship agreement with Japanese manufacturerJones Day is representing the distributor of a famous brand of Japanese cosmetics in arbitration proceedings against the Japanese manufacturer for wrongful termination of an exclusive distributorship agreement.
  • Sumitomo Chemical acquires 20% of NuFarm for $622 millionJones Day advised Sumitomo Chemical, a company listed on the Tokyo Stock Exchange ("Sumitomo") in its strategic investment and alliance with Nufarm Limited, a company listed on the Australian Securities Exchange and one of Australia's largest agro-chemical companies with an annual turnover in excess of $2.6 billion.
  • Sumitomo Chemical acquires MMA sheet business of Jiuh Mei EnterpriseJones Day advised Sumitomo Chemical Co., Ltd. in its acquisition of the methyl methacrylate (MMA) sheet business of Jiuh Mei Enterprise Co., Ltd.
  • Eco Asset participates in CDM (Clean Development Mechanism) projects in ChinaJones Day provided legal advice to Eco Asset Incorporated with respect to three CDM (Clean Development Mechanism) projects in China.
  • Major Japanese private equity firm performs due diligence in connection with prospective acquisition of Japanese electronics manufacturerJones Day advised a major Japanese private equity firm in connection with ex-Japan aspects, including diligence, of a prospective acquisition of a Japanese electronics manufacturer.
  • The Deutsch Group completes sale to WENDEL InvestissementJones Day advised The Deutsch Group in its $1.04 billion acquisition by WENDEL Investissement ("Wendel").
  • Parker Hannifin acquires 70% of the shares of Kuroda PneumaticsJones Day advised Parker Hannifin Corporation in its 70% acquisition of the shares of Kuroda Pneumatics Ltd., a wholly owned subsidiary of Kuroda Precision Industries Ltd.
  • NTT Data acquires controlling interest in The Revere GroupJones Day advised NTT Data Corporation, a Japan-based information technology company, in its acquisition of a controlling interest in The Revere Group, Ltd., a provider of business-driven technology services across the full lifecycle of an initiative.
  • NIF Ventures acquires Gakken Credit in MBOJones Day represented NIF Ventures Co., Ltd. in the management buyout of Gakken Credit Corporation, a provider of consumer installment credit services, loans, leasing, and consigned clerical works, in a going-private transaction.
  • adidas Japan KK receives tender offer from SalomonJones Day advised adidas Japan KK in the tender offer by Salomon S.A. for all of the outstanding shares of Salomon & Taylor Made Co., Ltd.
  • Sumitomo Chemical forms joint venture with Lyondell Chemical CorporationJones Day advised Sumitomo Chemical in the formation of joint venture with Lyondell Chemical Corporation for the manufacture, distribution and sale of propylene oxide.
  • Additional Publications

    • January 2019
      ジョーンズ・デイ・ホワイト・ペーパー:FCPA 2018年次レビュー
    • August 2018
      ジョーンズ・デイ・ニュースレター:Global Legal Update
    • July 2017
      Japan Legal Update | Vol. 27
    • January 2017
      ジョーンズ・デイ・コメンタリー:カリフォルニア州最高裁判所、労働者の待機が義務付けられた休憩時間(On Call Rest Period)はカリフォルニア州法によって禁じられている旨を判示
    • January 2012
      ジョーンズ・デイ・ニュースレター:Jones Day International Insolvency Practice
    • September 2011
      ニュースレター: Jones Day International Insolvency Practice

    Speaking Engagements

    • December 2010
      国際倒産法セミナー: 米国取引先企業の経営破綻の際に債権者がとりうる方策について
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.